Results 11 to 20 of about 399,293 (360)
DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. [PDF]
BackgroundInduction chemotherapy is a common therapeutic option for patients with locoregionally-advanced head and neck cancer (HNC), but it remains unclear which patients will benefit. In this study, we searched for biomarkers predicting the response of
Cohen, Ezra EW+13 more
core +16 more sources
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care [PDF]
The role of induction chemotherapy in nasopharyngeal carcinoma (NPC) remains controversial. The primary aim of this study was to use the National Cancer Database to evaluate the patterns of care of induction chemotherapy in NPC and its impact on overall ...
Adkins, Douglas+10 more
core +3 more sources
Randomized Trials of Induction Chemotherapy: A Critical Review
There are nine prospective randomized trials comparing induction chemotherapy with standard therapy published in either final form or as preliminary abstract reports. Only one of the six randomized trials critiqued was designed to account for all known prognostic factors, utilized an effective chemotherapy regimen, and had excellent compliance such ...
Arlene A. Forastiere
openaire +4 more sources
Orbital Myeloid Sarcoma in Acute Myeloid Leukemia: A Case Report [PDF]
Orbital myeloid sarcoma is a common presentation in acute myeloid leukemia. A 6 years old girl child presented with progressive proptosis of the left eye for two weeks with associated redness, watering, and reduced vision in the left eye.
Kishalay Baidya+3 more
doaj +1 more source
Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma. [PDF]
PURPOSE:The value of adding induction chemotherapy to chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains controversial, yet high-risk patients with LA-NPC have poor outcomes after chemoradiotherapy.
Xiao-Wen Lan+6 more
doaj +1 more source
Background and Objectives: This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are ...
Dan Liu+9 more
doaj +1 more source
Induction chemotherapy in recurrent, unresectable esthesioneuroblastoma
Kumar Prabhash+4 more
openaire +4 more sources
Background Although patients with positive lavage cytology (CY1) are classified as having stage IV disease, long-term survival without other unresectable factors (P0CY1) has been reported.
Akikazu Yago+6 more
doaj +1 more source
BackgroundFluoropyrimidine with platinum-based chemotherapy has become the standard of care for advanced gastric and gastroesophageal (GEJ) cancer.
Daniel Walden+6 more
doaj +1 more source
Background Hyperthermia has been reported to cause cancer stage regression, thus providing surgical opportunities in patients with unresectable tumors and improving the quality of life of patients by preserving certain organs.
Guoxin Ren+11 more
doaj +1 more source